PMV Pharmaceuticals, Inc. (PMVP)

PMV Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	37.98	40.88	38.53	109.12	173.29
Short-Term Investments	74.96	128.58	165.35	132.76	124.7
Cash & Short-Term Investments	112.94	169.45	203.88	241.88	297.99
Cash Growth	-33.35%	-16.89%	-15.71%	-18.83%	-17.55%
Other Current Assets	2.28	6.2	3.53	5.13	3.3
Total Current Assets	115.23	175.66	207.41	247.01	301.29
Net Property, Plant & Equipment	1.04	1.55	19.05	20.49	13.15
Long-Term Investments	-	13.84	25.51	2.5	16.91
Other Long-Term Assets	0.3	0.24	0.19	0.31	0.22
Total Assets	116.56	191.29	252.15	270.31	331.57
Accounts Payable	3.16	6.58	3.24	3	3.19
Accrued Expenses	7.86	7.44	9.94	7.31	8.63
Current Portion of Leases	0.4	0.35	0.85	0.53	0.4
Total Current Liabilities	11.42	14.37	14.03	10.83	12.22
Long-Term Leases	0.44	0.84	12.43	13.45	10.79
Total Long-Term Liabilities	0.44	0.84	12.43	13.45	10.79
Total Liabilities	11.85	15.21	26.46	24.28	23.01
Additional Paid-in Capital	551.08	544.65	535.47	487.52	476.36
Accumulated Other Comprehensive Income	0.08	0.14	0.22	-0.45	-0.08
Retained Earnings	-446.45	-368.71	-310	-241.04	-167.73
Shareholders' Equity	104.71	176.08	225.69	246.03	308.56
Total Liabilities & Equity	116.56	191.29	252.15	270.31	331.57
Total Debt	0.84	1.19	13.29	13.98	11.19
Net Cash (Debt)	112.11	168.26	190.59	227.9	286.79
Net Cash Growth	-33.38%	-11.72%	-16.37%	-20.54%	-20.65%
Net Cash Per Share	2.13	3.26	3.97	5.00	6.35
Book Value	104.71	176.08	225.69	246.03	308.56
Book Value Per Share	1.99	3.41	4.70	5.40	6.84
Tangible Book Value	104.71	176.08	225.69	246.03	308.56
Tangible Book Value Per Share	1.99	3.41	4.70	5.40	6.84

Updated Mar 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q